grant

Host range determinants of bacterial exfoliative toxins

Organization UNIVERSITY OF OREGONLocation EUGENE, UNITED STATESPosted 16 Aug 2023Deadline 31 Jul 2026
NIHUS FederalResearch GrantFY2024AddressAmino AcidsAnimalsAssayBacteriaBacterial InfectionsBindingBioassayBiochemicalBiological AssayBlebBlisterBone InfectionBullaBullous LesionCadherinsCell AdhesionCell BodyCell JunctionsCellsCellular AdhesionChromosome MappingCollectionComplexCrystallographiesCrystallographyCutaneous DisorderDermatosesDesmosomesDevelopmentDiseaseDisease OutbreaksDisorderDsg1 antigenEndocarditisEpidermisEpidermolysinsEsteroproteasesEvolutionExfoliatinsExfoliative ToxinsFutureGene LocalizationGene MappingGene Mapping GeneticsGenesGeneticGenetic AlterationGenetic ChangeGenetic DifferentiationGenetic DivergenceGenetic DiversityGenetic DriftGenetic VariationGenetic defectGenetics-MutagenesisGenus staphylococcusGoalsHost FactorHost Factor ProteinHumanImpetigoInfectionInfectious Skin DiseasesIntegration Host FactorsIntercellular JunctionsInvestigationKnowledgeLifeLinkage MappingMacula AdherensMapsMeasuresMediatingMembrane Protein GeneMembrane ProteinsMembrane-Associated ProteinsModelingModern ManMolecularMolecular InteractionMutagenesisMutagenesis Molecular BiologyMutationNatural SelectionsNode of BizzozeroOsteomyelitisOutbreaksPFAN proteinPathogenesisPathogenicityPathogenicity FactorsPemphigus foliaceus antigenPeptidasesPeptide HydrolasesPneumoniaPositionPositioning AttributePredispositionPrimatesPrimates MammalsProductionProtease GeneProteasesProteinasesProteinsProteolytic EnzymesRecombinantsResolutionRisk AssessmentRitter DiseaseS aureusS. aureusSepsisSiteSkinSkin DiseasesSkin Diseases and ManifestationsSoft Tissue InfectionsSpecificitySpot DesmosomeStaph aureusStaphylococcal Exfoliative ToxinStaphylococcal Scalded Skin SyndromeStaphylococcusStaphylococcus aureusSurfaceSurface ProteinsSusceptibilitySystemTestingTotal Human and Non-Human Gene MappingToxinTropismVariantVariationVesicationVirulenceVirulence FactorsWorkZoonosesZoonoticZoonotic Infectionaminoacidbacteria infectionbacteria pathogenbacterial diseasebacterial pathogenblood infectionbloodstream infectioncombinatorialcutaneous barriercutaneous diseasecutaneous infectiondermal barrierdermal diseasedermal disorderdesigndesigningdesmogleindesmoglein 1developmentalepidermal barriergenetic mappinggenome mutationhuman diseasehuman pathogenimprovedin vitro Assayinfected skinmicrobe pathogenmicrobial pathogenmutantnew drug treatmentsnew drugsnew pharmacological therapeuticnew therapeuticsnew therapynext generation therapeuticsnon-human primatenonhuman primatenovel drug treatmentsnovel drugsnovel pharmaco-therapeuticnovel pharmacological therapeuticnovel therapeuticsnovel therapypathogenpathogenic bacteriapathogenic microbepreventpreventingresolutionsskin barrierskin disorderskin infectionspillover event
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

PROJECT SUMMARY
The host range, or tropism, of pathogen virulence factors is a key determinant of infection. A

detailed understanding of host and pathogen mutations that control species tropism is required in

order to assess the risk of future zoonotic disease outbreaks, improve animal infection models, and

design new therapeutics that take advantage of host specificity.

The objective of this proposal is to define barriers to cross-species activity in bacterial

virulence factors at high resolution, leveraging staphylococcal exfoliative toxins as a study system.

Exfoliative toxins encoded by pathogenic bacteria in the genus Staphylococcus cause life-

threatening skin diseases including staphylococcal scalded skin syndrome and bullous impetigo

characterized by widespread blistering and damage to the epidermis. Exfoliative toxins are

proteases that act by selectively cleaving the skin desmosomal cadherin desmoglein-1, leading to

loss of epidermal barrier function and blister formation. Our central hypothesis is that virulence

factor activity is dependent on genetic compatibilities between hosts and pathogens, and that

interrogating these compatibilities will uncover specific barriers to host tropism. In preliminary work,

we found that genes encoding desmoglein-1 have undergone rapid evolution and repeated natural

selection across non-human primates within a small protein surface sufficient to restrict toxin activity.

We have also developed tractable in vitro assays to measure toxin cleavage of recombinant

desmglein-1 from various host species.

The Specific Aims of this proposal are to 1) generate a high-resolution map of mutations in

desmoglein-1 that restrict toxin tropism, and 2) test how toxin mutations at the desmoglein-1 binding

interface contribute to host tropism. In Aim 1 we will perform combinatorial mutagenesis of the toxin

recognition surface in desmoglein-1 to produce a genetic map defining the barriers of host

recognition. In Aim 2 we will apply structural and biochemical approaches to resolve the desmoglein-

exfoliative toxin binding interface combined with genetics to assess how toxin mutations at this

surface control host tropism. Collectively this proposal will establish a framework to define genetic

barriers to bacterial infections at high-resolution, applied towards the goal of anticipating and

preventing future disease outbreaks.

Grant Number: 5R21AI173839-02
NIH Institute/Center: NIH

Principal Investigator: Matthew Barber

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →